Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | 서은경 | * |
| dc.date.accessioned | 2025-08-07T07:10:39Z | - |
| dc.date.available | 2025-08-07T07:10:39Z | - |
| dc.date.issued | 2025 | * |
| dc.identifier.issn | 0009-2797 | * |
| dc.identifier.other | OAK-37385 | * |
| dc.identifier.uri | https://dspace.ewha.ac.kr/handle/2015.oak/271944 | - |
| dc.description.abstract | Traumatic brain injury (TBI) is an acquired neurological insult that has become a major cause of mortality.Hence, immediate and appropriate medical attention is essential. The present study investigated the neuroprotective effect of 7β-(3-ethyl-cis-crotonoyloxy)-1α-(2-methylbutyryloxy)-3,14-dehydro-Z-notonipetranone (ECN), a sesquiterpenoid against a weight drop model of traumatic brain injury (TBI). During the in-vitro analysis, ECN demonstrated neuroprotective potential by remarkably improving the cell viability and also provided significant protection in case of nitric oxide-evoked oxidative stress in HT22 cells. The administration of ECN significantly improved the neurological severity score, and mechanical/periorbital allodynia following TBI, when compared with the TBI-group. The level of brain edema and blood-brain barrier (BBB) disruption were also significantly reduced by ECN treatment. ECN also restored constitutional changes in the protein/lipid profile; simultaneous with histological changes in the brain in contrast to the TBI-group. It significantly ameliorated neuronal loss and also minimized the intracerebral hemorrhages arising from traumatic insult. ECN exhibited potent anti-inflammatory effects, by altering the expression of extracellular-signal-regulated kinase (ERK), p38, and activating protein-1 (AP-1) proteins. It also exhibited antioxidant effects by increasing the production levels of nuclear factor erythroid 2–related factor 2 (Nrf2) and heme oxygenase-1 (HO-1). Furthermore, ECN also produced an anti-apoptotic effect by downregulation of caspase3 and upregulation of B-cell lymphoma 2 (Bcl-2). It also increased the levels of antioxidants while reducing the levels of oxidative stress and inflammatory markers in comparison to the TBI-group. In short, it was concluded that ECN exhibited protective anti-inflammatory, antioxidant, and anti-apoptotic effects against trauma-induced brain injury. © 2025 Elsevier B.V., All rights reserved. | * |
| dc.language | English | * |
| dc.publisher | Elsevier Ireland Ltd | * |
| dc.subject | Antioxidants | * |
| dc.subject | Apoptosis | * |
| dc.subject | Ecn | * |
| dc.subject | Inflammation | * |
| dc.subject | Neuroprotection | * |
| dc.subject | Traumatic Brain Injury | * |
| dc.subject | Caspase 3 | * |
| dc.subject | Catalase | * |
| dc.subject | Crystal Violet | * |
| dc.subject | Eosin | * |
| dc.subject | Glutathione | * |
| dc.subject | Glutathione Transferase | * |
| dc.subject | Hematoxylin | * |
| dc.subject | Mitogen Activated Protein Kinase | * |
| dc.subject | Myeloperoxidase | * |
| dc.subject | Nitric Oxide | * |
| dc.subject | Protein Bcl 2 | * |
| dc.subject | Superoxide Dismutase | * |
| dc.subject | Heme Oxygenase-1 | * |
| dc.subject | Mitogen-activated Protein Kinases | * |
| dc.subject | Neuroprotective Agents | * |
| dc.subject | Nf-e2-related Factor 2 | * |
| dc.subject | Nfe2l2 Protein, Mouse | * |
| dc.subject | Sesquiterpenes | * |
| dc.subject | Graph Pad Version 8.0.1.244 | * |
| dc.subject | Image J Software | * |
| dc.subject | Origin Pro Software V 9.6.5.169 | * |
| dc.subject | Skanit Re 4.1 | * |
| dc.subject | 7beta (3 Ethyl Cis Crotonoyloxy) 1alpha (2 Methylbutyryloxy) 3,14 Dehydro Z Notonipetranone | * |
| dc.subject | Antioxidant | * |
| dc.subject | Heme Oxygenase 1 | * |
| dc.subject | Interleukin 1beta | * |
| dc.subject | Lipid Peroxidase | * |
| dc.subject | Reactive Oxygen Metabolite | * |
| dc.subject | Sesquiterpenoid | * |
| dc.subject | Synaptophysin | * |
| dc.subject | Transcription Factor Ap 1 | * |
| dc.subject | Transcription Factor Nrf2 | * |
| dc.subject | Tumor Necrosis Factor | * |
| dc.subject | Unclassified Drug | * |
| dc.subject | Neuroprotective Agent | * |
| dc.subject | Sesquiterpene | * |
| dc.subject | Animal Cell | * |
| dc.subject | Animal Experiment | * |
| dc.subject | Animal Model | * |
| dc.subject | Animal Tissue | * |
| dc.subject | Antiinflammatory Activity | * |
| dc.subject | Antioxidant Activity | * |
| dc.subject | Article | * |
| dc.subject | Blood Brain Barrier | * |
| dc.subject | Brain Edema | * |
| dc.subject | Brain Hemorrhage | * |
| dc.subject | Cell Viability | * |
| dc.subject | Differential Scanning Calorimetry | * |
| dc.subject | Fourier Transform Infrared Spectroscopy | * |
| dc.subject | Histology | * |
| dc.subject | Ht22 Cell Line | * |
| dc.subject | Immunohistochemistry | * |
| dc.subject | In Vitro Study | * |
| dc.subject | Male | * |
| dc.subject | Mapk Signaling | * |
| dc.subject | Mechanical Allodynia | * |
| dc.subject | Mouse | * |
| dc.subject | Mtt Assay | * |
| dc.subject | Neurologic Disease Assessment | * |
| dc.subject | Neurological Severity Scoring | * |
| dc.subject | Nonhuman | * |
| dc.subject | Nrf2 Ho 1 Signaling | * |
| dc.subject | Oxidative Stress | * |
| dc.subject | Real Time Polymerase Chain Reaction | * |
| dc.subject | Scoring System | * |
| dc.subject | Signal Transduction | * |
| dc.subject | Thermogravimetry | * |
| dc.subject | Von Frey Test | * |
| dc.subject | Animal | * |
| dc.subject | Cell Line | * |
| dc.subject | Cell Survival | * |
| dc.subject | Chemistry | * |
| dc.subject | Drug Effect | * |
| dc.subject | Drug Therapy | * |
| dc.subject | Metabolism | * |
| dc.subject | Pathology | * |
| dc.subject | Animals | * |
| dc.subject | Blood-brain Barrier | * |
| dc.subject | Brain Injuries, Traumatic | * |
| dc.subject | Mice | * |
| dc.title | 7β-(3-ethyl-cis-crotonoyloxy)-1α-(2-methylbutyryloxy)-3,14-dehydro-Z-notonipetranone (ECN) attenuates inflammation and oxidative stress via MAPK, and Nrf2/HO-1 signaling in Traumatic brain injury | * |
| dc.type | Article | * |
| dc.relation.volume | 415 | * |
| dc.relation.index | SCIE | * |
| dc.relation.index | SCOPUS | * |
| dc.relation.journaltitle | Chemico-Biological Interactions | * |
| dc.identifier.doi | 10.1016/j.cbi.2025.111510 | * |
| dc.identifier.wosid | WOS:001473799600001 | * |
| dc.identifier.scopusid | 2-s2.0-105002579508 | * |
| dc.author.google | Zafar S. | * |
| dc.author.google | Jamil M. | * |
| dc.author.google | Khan M.I. | * |
| dc.author.google | Din F.U. | * |
| dc.author.google | Seo E.K. | * |
| dc.author.google | Khan S. | * |
| dc.contributor.scopusid | 서은경(7005953758) | * |
| dc.date.modifydate | 20261006123658 | * |